Study of V940 Plus Pembrolizumab Versus Placebo Plus Pembrolizumab in Patients with Non-Small Cell Lung Cancer | Clinical Trial

Study of V940 Plus Pembrolizumab Versus Placebo Plus Pembrolizumab in Patients with Non-Small Cell Lung Cancer | Clinical Trial | Right2Hope